4
Changes in Ownership
Atrium Therapeutics, Inc. Filed Acc 0001193125-26-170960
Chief Financial Officer acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Winslow Brendan R. Chief Financial Officer | 2026-04-20 | Grant or award | +30,000 | 43,601 | D | ||
| Derivatives | |||||||
| Winslow Brendan R. Chief Financial Officer | 2026-04-20 | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | D | ||
Loading xslF345X06/ownership.xml…